Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07344571
Active, not recruiting Observational

Investigating the Correlation Between Functional Constipation and Sacroiliac Joint Disorders

NCT07344571 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2023-04-15
Last updated
2026-01-15

Condition(s) studied

Constipation

Study summary

Constipation is a common gastrointestinal issue affecting individuals worldwide. Interferential therapy, a form of electrotherapy, has been suggested to have potential benefits in improving gastrointestinal motility and relieving constipation symptoms. Introducing of a new method like electronic cupping therapy with interferential therapy may optimize the therapeutic outcomes by potentially increasing bowel movements and improving overall gastrointestinal function.

Eligibility

Sex
ALL
Min age
25 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Inclusion Criteria: * history of Chronic Constipation (CC), as defined by either experiencing two or fewer Complete Spontaneous Bowel Movements (CSBMs) per week for a minimum of 6 consecutive months before the screening visit * Reporting a sensation of incomplete evacuation or straining during at least a quarter of their bowel movements (according to the generally accepted definition of constipation). * Patients must have had CC persisting for more than 6 months, failed to respond to or be intolerant of medical treatment for at least 3 months Inclusion Criteria (for group B): Not having functional constipation Exclusion Criteria: * \- pregnant or lactating women * Chronic Constipation (CC) resulting from anorectal malformations such as colorectal or anal organic lesions, pelvic floor disorders requiring surgical intervention as determined by the investigator (such as rectal prolapse, rectocele, or enterocele) * presence of implanted electronic devices like cardiac pacemakers, defibrillators, cardiac pumps, or spinal stimulators * CC attributable to medications or neurologic, endocrine, or metabolic conditions * prior history of partial colectomy; conditions like megacolon, megarectum, or colonic inertia * skin abnormalities that hinder the placement of electrodes * women lacking adequate contraception (hormonal or intrauterine device).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bassam Ahmed Nabil October City Giza Governorate

More Middle East University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07344571 on ClinicalTrials.gov ↗ ← All trials in Egypt